Adhesion molecule–targeted magnetic particle imaging nanoprobe for visualization of inflammation in acute lung injury

Purpose Uncontrolled intra-alveolar inflammation is a central pathogenic feature, and its severity translates into a valid prognostic indicator of acute lung injury (ALI). Unfortunately, current clinical imaging approaches are unsuitable for visualizing and quantifying intra-alveolar inflammation. This study aimed to construct a small-sized vascular cell adhesion molecule-1 (VCAM-1)-targeted magnetic particle imaging (MPI) nanoprobe (ESPVPN) to visualize and accurately quantify intra-alveolar inflammation at the molecular level. Methods ESPVPN was engineered by conjugating a peptide (VHPKQHRGGSK(Cy7)GC) onto a polydopamine-functionalized superparamagnetic iron oxide core. The MPI performance, targeting, and biosafety of the ESPVPN were characterized. VCAM-1 expression in HUVECs and mouse models was evaluated by western blot. The degree of inflammation and distribution of VCAM-1 in the lungs were assessed using histopathology. The expression of pro-inflammatory markers and VCAM-1 in lung tissue lysates was measured using ELISA. After intravenous administration of ESPVPN, MPI and CT imaging were used to analyze the distribution of ESPVPN in the lungs of the LPS-induced ALI models. Results The small-sized (~10 nm) ESPVPN exhibited superior MPI performance compared to commercial $ MagImaging^{®} $ and Vivotrax, and ESPVPN had effective targeting and biosafety. VCAM-1 was highly expressed in LPS-induced ALI mice. VCAM-1 expression was positively correlated with the LPS-induced dose (R = 0.9381). The in vivo MPI signal showed positive correlations with both VCAM-1 expression (R = 0.9186) and representative pro-inflammatory markers (MPO, TNF-α, IL-6, IL-8, and IL-1β, R > 0.7). Conclusion ESPVPN effectively targeted inflammatory lungs and combined the advantages of MPI quantitative imaging to visualize and evaluate the degree of ALI inflammation..

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:51

Enthalten in:

European journal of nuclear medicine and molecular imaging - 51(2023), 5 vom: 14. Dez., Seite 1233-1245

Sprache:

Englisch

Beteiligte Personen:

Gao, Pengli [VerfasserIn]
Liu, Yu [VerfasserIn]
Wang, Xiaoli [VerfasserIn]
Feng, Xin [VerfasserIn]
Liu, Heng [VerfasserIn]
Liu, Songlu [VerfasserIn]
Huang, Xiazi [VerfasserIn]
Wu, Xiangjun [VerfasserIn]
Xiong, Fei [VerfasserIn]
Jia, Xiaohua [VerfasserIn]
Hui, Hui [VerfasserIn]
Jiang, Jingying [VerfasserIn]
Tian, Jie [VerfasserIn]

Links:

Volltext [lizenzpflichtig]

BKL:

44.64

Themen:

Acute lung injury
Inflammation
Magnetic particle imaging
Vascular cell adhesion molecule-1

Anmerkungen:

© The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

doi:

10.1007/s00259-023-06550-4

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

SPR055233929